References
- Asada Y, Tsuruta M, Okabayashi K, et al. Inhibition of heat-shock protein 27 reduces 5-fluorouracil-acquired resistance in human colon cancer cells. Anticancer Res. 2021;41(3):1283–1290. doi:10.21873/anticanres.14885
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
- Schmidt S, Follmann M, Malek N, et al. Critical appraisal of clinical practice guidelines for diagnosis and treatment of hepatocellular carcinoma. J Gastroenterol Hepatol. 2011;26(12):1779–1786. doi:10.1111/j.1440-1746.2011.06891.x
- Yu SJ. A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010–2016. Clin Mol Hepatol. 2016;22(1):7–17. doi:10.3350/cmh.2016.22.1.7
- Sangro B, Sarobe P, Hervás-Stubbs S, Melero I. Advances in immunotherapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2021;18:525–543.
- Zhu AX, Finn RS, Edeline J, et al. Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label Phase 2 trial. Lancet Oncol. 2018;19(7):940–952. doi:10.1016/S1470-2045(18)30351-6
- Stockwell BR, Jiang X, Gu W. Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol. 2020;30(6):478–490. doi:10.1016/j.tcb.2020.02.009
- Chen X, Li J, Kang R, et al. Ferroptosis: machinery and regulation. Autophagy. 2020:1–28. doi:10.1080/15548627.2020.1810918
- Du X, Zhang Y. Integrated analysis of immunity- and ferroptosis-related biomarker signatures to improve the prognosis prediction of hepatocellular carcinoma. Front Genet. 2020;11:614888. doi:10.3389/fgene.2020.614888
- Mahoney-Sánchez L, Bouchaoui H, Ayton S, et al. Ferroptosis and its potential role in the physiopathology of parkinson’s disease. Prog Neurobiol. 2021;196:101890. doi:10.1016/j.pneurobio.2020.101890
- Guo J, Xu B, Han Q, et al. Ferroptosis: a novel anti-tumor action for cisplatin. Cancer Res Treat. 2018;50(2):445–460. doi:10.4143/crt.2016.572
- Liu Y, Guo F, Guo W, et al. Ferroptosis-related genes are potential prognostic molecular markers for patients with colorectal cancer. Clin Exp Med. 2021;21(3):467–477. doi:10.1007/s10238-021-00697-w
- Sun X, Ou Z, Xie M, et al. HSPB1 as a novel regulator of ferroptotic cancer cell death. Oncogene. 2015;34(45):5617–5625. doi:10.1038/onc.2015.32
- Xie Y, Hou W, Song X, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23(3):369–379. doi:10.1038/cdd.2015.158
- Lu H, Sun C, Zhou T, et al. HSP27 knockdown increases cytoplasmic p21 and cisplatin sensitivity in ovarian carcinoma cells. Oncol Res. 2016;23(3):119–128. doi:10.3727/096504015X14496932933656
- Hsu H-S, Lin J-H, Huang W-C, et al. Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27. Cancer. 2011;117(7):1516–1528. doi:10.1002/cncr.25599
- Stope MB, Weiss M, Preuss M, et al. Immediate and transient phosphorylation of the heat shock protein 27 initiates chemoresistance in prostate cancer cells. Oncol Rep. 2014;32(6):2380–2386. doi:10.3892/or.2014.3492
- Jin HO, Hong SE, Kim JY, et al. Induction of HSP27 and HSP70 by constitutive overexpression of Redd1 confers resistance of lung cancer cells to ionizing radiation. Oncol Rep. 2019;41(5):3119–3126.
- Fei Z, Lijuan Y, Jing Z, et al. Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression. Hum Cell. 2021;34(1):177–186. doi:10.1007/s13577-020-00431-w
- Choi C, Kam H, Kim KY, Park SI, Lee YS. Targeting heat shock protein 27 in cancer: a druggable target for cancer treatment? Cancers. 2019;11(8):1195. doi:10.3390/cancers11081195
- Calderwood SK, Gong J. Heat shock proteins promote cancer: it’s a protection racket. Trends Biochem Sci. 2016;41(4):311–323. doi:10.1016/j.tibs.2016.01.003
- Choi S-H, Lee H-J, Jin YB, et al. MMP9 processing of HSPB1 regulates tumor progression. PLoS One. 2014;9(1):e85509. doi:10.1371/journal.pone.0085509
- Thuringer D, Jego G, Wettstein G, et al. Extracellular HSP27 mediates angiogenesis through toll-like receptor 3. FASEB J. 2013;27(10):4169–4183. doi:10.1096/fj.12-226977
- Pavan S, Musiani D, Torchiaro E, et al. HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor. Int J Cancer. 2014;134(6):1289–1299. doi:10.1002/ijc.28464
- Cordonnier T, Bishop JL, Shiota M, et al. Hsp27 regulates EGF/β-catenin mediated epithelial to mesenchymal transition in prostate cancer. Int J Cancer. 2015;136(6):E496–E507. doi:10.1002/ijc.29122
- Dixon SJ, Stockwell BR. The role of iron and reactive oxygen species in cell death. Nat Chem Biol. 2014;10(1):9–17. doi:10.1038/nchembio.1416
- Salnikow K. Role of iron in cancer. Semin Cancer Biol. 2021. doi:10.1016/j.semcancer.2021.04.001
- Liu J, Kang R, Tang D. Signaling pathways and defense mechanisms of ferroptosis. FEBS J. 2021. doi:10.1111/febs.16059
- Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273–285. doi:10.1016/j.cell.2017.09.021
- Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 2016;26(3):165–176. doi:10.1016/j.tcb.2015.10.014
- Saran U, Humar B, Kolly P, et al. Hepatocellular carcinoma and lifestyles. J Hepatol. 2016;64(1):203–214. doi:10.1016/j.jhep.2015.08.028
- An L, Zeng HM, Zheng RS, et al. [Liver cancer epidemiology in China, 2015]. Zhonghua Zhong Liu Za Zhi. 2019;41(10):721–727. Chinese.
- Ndiaye H, Liu J, Hall A, et al. Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases. Biosci Rep. 2020;40(4):BSR20200219. doi:10.1042/BSR20200219